1. Home
  2. CWBC vs ARVN Comparison

CWBC vs ARVN Comparison

Compare CWBC & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community West Bancshares

CWBC

Community West Bancshares

HOLD

Current Price

$26.04

Market Cap

701.6M

Sector

Finance

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$7.34

Market Cap

600.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWBC
ARVN
Founded
1989
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
701.6M
600.2M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
CWBC
ARVN
Price
$26.04
$7.34
Analyst Decision
Buy
Buy
Analyst Count
6
16
Target Price
★ $29.70
$13.93
AVG Volume (30 Days)
165.4K
★ 646.8K
Earning Date
10-22-2026
11-04-2026
Dividend Yield
★ 1.83%
N/A
EPS Growth
★ 344.44
58.84
EPS
0.61
★ 1.70
Revenue
N/A
★ $262,600,000.00
Revenue This Year
$41.04
$12.76
Revenue Next Year
$13.98
N/A
P/E Ratio
$42.98
★ $4.54
Revenue Growth
★ N/A
N/A
52 Week Low
$20.70
$6.74
52 Week High
$28.17
$14.22

Technical Indicators

Market Signals
Indicator
CWBC
ARVN
Relative Strength Index (RSI) 50.66 43.63
Support Level $25.05 $6.74
Resistance Level $26.43 $7.74
Average True Range (ATR) 0.68 0.36
MACD -0.01 0.08
Stochastic Oscillator 51.08 51.43

Price Performance

Historical Comparison
CWBC
ARVN

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments. The company has one reportable segment: Banking operations. Loans and leases, investment securities, interest-bearing deposits and non-interest income provide the revenues of the banking operation.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: